As shown in Fig. 3b, the western blot results showed that the expression levels of p53 and p-p53 in HCT116, and p-p53 in SW480 were significantly increased following pyrimethamine treatment, indicating that pyrimethamine could activate the p53 pathway in CRC. This evidence concerns the gene TP53 and colorectal carcinoma.